International Clinical Trial: Phase ? Clinical Study on the Efficacy and Safety of SBRT Combined With Vibecotamab in EGFR-Positive Metastatic Tumor Patients With Oligometastases

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126603) titled 'Phase ? Clinical Study on the Efficacy and Safety of SBRT Combined With Vibecotamab in EGFR-Positive Metastatic Tumor Patients With Oligometastases' on June 12.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University

Condition: For patients with EGFR-positive malignant tumors and oligometastases whose primary lesion has been radically treated and is well-controlled.

Intervention: Trial group:Becotatug vedotin plus SBRT and investigator's choice of treatment regimen

Recruitment Status: Recruiting

Phase: 3

Date of First Enrollment: 2026-...